What You Need to Know About Apellis Pharmaceuticals' April 2025 Board Appointment

Apellis Pharmaceuticals Appointed a New Board Member in April 2025

Apellis Pharmaceuticals, a biopharmaceutical company focused on complement-driven diseases, announced a board appointment in April 2025. The company added a new member to its board of directors during this period. This type of corporate governance change is public information, typically disclosed through SEC filings and company press releases.

Board appointments at publicly traded companies follow formal procedures set by the company's bylaws and shareholder agreements. The appointment reflects decisions made by the board's nominating and governance committee, which evaluates candidates based on expertise, industry experience, and strategic fit with the company's direction.

Key Takeaways

• Board appointments at public companies are disclosed through SEC filings, press releases, and the company's investor relations website.
• The nominating and governance committee typically reviews and recommends board candidates based on skills, experience, and strategic needs.
• Shareholders may have voting rights on board appointments depending on the company's bylaws and the appointment method used.
• Board member information, including names, titles, and biographical details, is available in the company's proxy statements and annual reports.

Where Board Appointment Information Is Published

When a publicly traded company like Apellis Pharmaceuticals appoints a new board member, the announcement appears in multiple official places. The company's investor relations website typically posts a press release with the appointee's name, background, and role. This is usually the fastest way to find current information about the appointment.

The SEC's EDGAR database contains formal filings related to board changes. Form 8-K is filed when a material event occurs, including significant board appointments. Apellis Pharmaceuticals' proxy statement (filed annually as a DEF 14A) lists all current board members, their backgrounds, committee assignments, and compensation details.

The company's annual report and 10-K filing also include board composition information. These documents are required by law and provide the most detailed picture of board structure and governance practices.

How Board Members Are Selected and Appointed

The nominating and governance committee of Apellis Pharmaceuticals' board is responsible for identifying and recommending new board candidates. This committee reviews potential appointees based on criteria such as industry expertise, financial acumen, regulatory knowledge, and diversity of background and perspective. The committee may work with external search firms to identify may have access to candidates.

Once a candidate is identified and vetted, the full board votes on the appointment. Depending on the company's bylaws, the appointment may be made by the board alone or may require shareholder approval at the next annual meeting. Some appointments are made to fill vacancies, while others expand the board size.

The board member typically signs a director agreement outlining duties, compensation, insurance coverage, and indemnification. Board members are expected to attend meetings regularly, serve on committees, and act in the best interest of shareholders.

What Information Is Available About the Appointee

When Apellis Pharmaceuticals announces a board appointment, the company releases biographical information about the new member. This typically includes their professional background, current and past positions, educational credentials, and relevant expertise. The press release explains why the appointee's skills align with the company's strategic priorities.

The company's proxy statement provides more detailed information, including the appointee's age, tenure on the board, committee assignments, and any related-party transactions. It also discloses any material relationships between the board member and the company or its management.

You can also search for the appointee's professional background through business databases like LinkedIn, Bloomberg, or company websites where they may hold other positions. This helps you understand their broader experience and track record in the industry.

Board Committees and Responsibilities

New board members at Apellis Pharmaceuticals are typically assigned to one or more committees based on their expertise. Common committees include audit, compensation, nominating and governance, and scientific or clinical committees. Committee assignments are disclosed in the proxy statement and press releases.

Committee membership carries specific responsibilities. For example, audit committee members must have financial expertise and oversee the company's financial reporting and internal controls. Compensation committee members review executive pay and incentive plans. These assignments influence the appointee's workload and areas of focus.

How Shareholders May Be Involved

Depending on how the appointment was made, shareholders may have had a vote on the new board member. If the appointment was made to fill a vacancy or expand the board, shareholders typically vote on it at the next annual meeting. The proxy statement sent before the meeting includes information about the appointee and a recommendation from the board.

Shareholders can vote for or against the appointee, though in practice most board-recommended candidates receive strong support. Some shareholders may abstain or vote against if they have concerns about the candidate's background or the board's composition.

If you hold shares in Apellis Pharmaceuticals, you receive proxy materials before the annual meeting. These materials include detailed information about all board members and any new appointees, allowing you to make an informed voting decision.

Finding the Official Announcement and Documents

To locate information about Apellis Pharmaceuticals' April 2025 board appointment, start with the company's investor relations website. Search for press releases from April 2025 or use the site's news archive. The press release will have the appointee's name, title, and a summary of their background.

Next, check the SEC's EDGAR database by searching for Apellis Pharmaceuticals' recent filings. Look for Form 8-K filings from April 2025, which would disclose the appointment as a material event. You can also download the most recent proxy statement (DEF 14A) to see the full board roster and committee assignments.

If you need more detail, contact Apellis Pharmaceuticals' investor relations department directly. They can provide copies of press releases, proxy statements, and answer questions about board composition and governance practices.

Frequently Asked Questions

Where can I find the name of the board member appointed in April 2025?

The company's investor relations website has the press release announcing the appointment. You can also search the SEC's EDGAR database for Apellis Pharmaceuticals' Form 8-K filings from April 2025. The most recent proxy statement (DEF 14A) lists all current board members.

What does a board member actually do at a pharmaceutical company?

Board members attend quarterly meetings, review financial and operational performance, oversee strategy, and ensure compliance with regulations. At a pharmaceutical company, they also monitor clinical trial progress, regulatory submissions, and drug development timelines. They serve on committees focused on audit, compensation, and sometimes scientific matters.

Can shareholders vote on board appointments after they are made?

Yes, if the appointment was made to fill a vacancy or expand the board, shareholders vote on it at the next annual meeting. If the board appointed someone to an existing seat between annual meetings, shareholders ratify the appointment at the following annual meeting. The proxy statement explains the appointment and includes voting instructions.

How do I know if a board member has conflicts of interest?

The proxy statement discloses any material relationships between board members and the company, including business dealings, family ties, or financial interests. Board members are required to recuse themselves from votes where they have a conflict. You can also review the appointee's other board positions and business affiliations through public databases.

What happens if shareholders vote against a board member?

If a board member receives a majority vote against, most companies have a policy requiring the director to offer their resignation. The board then decides whether to accept it. This rarely happens with board-recommended candidates, but it can occur if shareholders have significant concerns about governance or the director's performance.